{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:14:05Z","timestamp":1788336845415,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jdcr.2026.03.036","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:43:27Z","timestamp":1774514607000},"page":"194-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acquired perforating dermatosis associated with uremic pruritus treated with dupilumab monotherapy: A case report"],"prefix":"10.1016","volume":"71","author":[{"given":"Sara","family":"Mubarak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayam","family":"AlEnezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danah I.","family":"AlKandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Sadat","family":"Mosbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer","family":"AlAlawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2026.03.036_bib1","article-title":"Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jdcr.2026.03.036_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.574","article-title":"Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD","volume":"10","author":"Ying","year":"2022","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jdcr.2026.03.036_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jdcr.2022.08.013","article-title":"Dupilumab in acquired perforating dermatosis: a potential new treatment","volume":"28","author":"Alsebayel","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jdcr.2026.03.036_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jdcr.2019.01.024","article-title":"A successful case of dupilumab treatment for severe uremic pruritus","volume":"5","author":"Silverberg","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"5","key":"10.1016\/j.jdcr.2026.03.036_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","article-title":"Treatment of uremic pruritus: a systematic review","volume":"70","author":"Simonsen","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.jdcr.2026.03.036_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2014.08.004","article-title":"Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis","volume":"71","author":"Ko","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2026.03.036_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s13555-022-00737-7","article-title":"Current and emerging strategies to inhibit type 2 inflammation in atopic dermatitis","volume":"12","author":"Haddad","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"10.1016\/j.jdcr.2026.03.036_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jid.2025.08.012","article-title":"Cutaneous neuroanatomical and cellular response to dupilumab treatment in atopic dermatitis","volume":"146","author":"Wiegmann","year":"2026","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.03.036_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2020.05.028","article-title":"New and emerging treatments for inflammatory itch","volume":"126","author":"Erickson","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jdcr.2026.03.036_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/medicines6030072","article-title":"Chronic pruritus responding to Dupilumab\u2014A case series","volume":"6","author":"Zhai","year":"2019","journal-title":"Medicines"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626001682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626001682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:22:40Z","timestamp":1788333760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626001682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":10,"alternative-id":["S2352512626001682"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.03.036","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired perforating dermatosis associated with uremic pruritus treated with dupilumab monotherapy: A case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}